Business
Synergy CHC (NASDAQ: SNYR) Expands FOCUSfactor® to UAE & Turkey — Ignites Global Growth and New Revenue Streams
WESTBROOK, Maine, June 18, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a fast-growing consumer health and wellness company, announced today that it has expanded its international licensing deal with Gravity Pharma, adding Turkey alongside the United Arab Emirates UAE for exclusive distribution of FOCUSfactor®. This move brings total upfront licensing revenue to $2 million, with additional performance-based royalties tied to product sales across both hi
About this update from Synergy Chc Corp.
[{"type":"image","alt":"Synergy CHC Corp.","displaySize":"","headline":null,"caption":"Synergy CHC Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":294,"height":62,"url":"https://media.zenfs.com/en/globenewswire.com/db32691150c737c93f90b78b981034ac"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/yA4qgUAvhjK.xTwWG4ZQRw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTg5O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/db32691150c737c93f90b78b981034ac","width":294,"height":62}},"lazy":false},{"type":"text","content":"WESTBROOK, Maine, June 18, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a fast-growing consumer health and wellness company, announced today that it has expanded its international licensing deal with Gravity Pharma, adding Turkey alongside the United Arab Emirates UAE for exclusive distribution of FOCUSfactor®. This move brings total upfront licensing revenue to $2 million, with additional performance-based royalties tied to product sales across both high-growth markets.","length":518,"tagName":"p"},{"type":"text","content":""This isn’t just an expansion—it’s execution," said Jack Ross, CEO of Synergy CHC Corp. “Adding Turkey alongside the United Arab Emirates (UAE), compounds our momentum and unlocks untapped growth in scalable, capital-efficient markets. We’re building brand equity globally without the overhead—exactly how growth should look in 2025.”","length":344,"tagName":"p"},{"type":"text","content":"The UAE-Turkey licensing model allows Synergy to scale the FOCUSfactor® brand—including brain health supplements, cognitive beverages, and energy shots—without diluting ownership or diverting U.S.-based operational focus. Synergy retains 100% ownership and global IP, with performance-based royalties driving long-term upside.","length":326,"tagName":"p"},{"type":"text","content":"Key Highlights for Investors:","length":29,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"$2M in licensing secured","length":24,"tagName":"p"}]},{"val":[{"type":"text","content":"Additional revenue potential through royalties","length":46,"tagName":"p"}]},{"val":[{"type":"text","content":"Scalable, asset-light growth strategy","length":37,"tagName":"p"}]},{"val":[{"type":"text","content":"Brain health market expected to top $20B by 2030","length":48,"tagName":...